A new supplement issue of The Gerontological Society of America’s journal The Gerontologist marks 20 years of public health leadership on dementia through the U.S. Centers for Disease Control and Prevention’s Healthy Brain Initiative (HBI) and highlights unprecedented progress in establishing dementia as a public health priority nationwide. Accelerated through implementation of the federal government’s Building Our Largest Dementia Infrastructure (BOLD) Act, the supplement documents how brain health, dementia risk reduction, early detection, and caregiving are now core components of public health practice.

The American College of Cardiology’s Global Quality Solutions program now offers international hospitals and health systems a new pathway to achieving ACC Accreditation. Previously, these sites were required to submit data through the associated NCDR registry to be eligible for accreditation. However, local data and privacy regulations often made participation in a U.S.- based data registry challenging. The updated process will allow eligible sites to internally collect and submit aggregated data directly into ACC Accreditation tools to meet accreditation requirements. 

New research from George Mason University warns that AI-driven antidepressant treatment may overlook the needs and experiences of African Americans with depression.

Researchers from the Centre for Addiction and Mental Health (CAMH) and the Institute of Neurophysiology at Uniklinik RWTH Aachen in Germany have deciphered the molecular signature of so-called sleeping nociceptors—a type of pain-sensing nerve cell that normally remains quiet and does not respond to touch or pressure, but can become overactive and drive chronic pain. The findings will be published on February 4 in the renowned scientific journal Cell.

About The Study: In this systematic review and meta-analysis of equity, diversity, and inclusion (EDI) initiatives in health care institutions, programs were associated with an increased workforce diversity. These findings support the continued use of EDI initiatives to promote a more inclusive and equitable health care culture.

About The Study: In this randomized clinical trial, a ketogenic diet had antidepressant benefits compared with a well-matched control diet at 6 weeks. However, the clinical relevance is uncertain, as the mean effect size compared with the control was modest and not evident in secondary analyses.